Ortho Regenerative Technologies (CSE:ORTH) Inc CEO Philippe Deschamps tells Proactive that the United States Patent and Trademark Office (USPTO) has issued a patent related to the company's ORTHO-R soft tissue repair platform.
The patent, titled ‘Freeze-Dried Polymer Compositions for mixing with platelet rich plasma to form implants for tissue repair and/or composition for therapeutic intra-articular injection’, provides broad protection for both the composition and the method of use of its Ortho-R Technology, the company said.